Is Allstate Stock Underperforming the Nasdaq?

Company Overview - The Allstate Corporation has a market cap of $52.7 billion and is one of the largest publicly held personal lines insurers in the U.S. [1] - The company operates through five business segments, offering a variety of property, casualty, life, health, and protection products to individuals, households, and employers in the U.S. and Canada [1]. Stock Performance - Allstate's shares have declined 6.8% from its 52-week high of $214.76, while the stock has risen 1.6% over the past three months, underperforming the Nasdaq Composite's 11.7% increase [3]. - Year-to-date, ALL stock is up 3.6%, lagging behind the Nasdaq's 13.3% gain, and has gained nearly 8% over the past 52 weeks compared to the Nasdaq's 29.6% return [4]. Financial Results - Following Q2 2025 results, Allstate shares rose 5.7% as the insurer posted adjusted EPS of $5.94, exceeding analyst expectations [5]. - The strong performance was attributed to a turnaround in the property-liability segment, with underwriting income increasing to $1.28 billion from a loss a year earlier, and the underlying combined ratio improving to 79.5% [5]. - Higher net investment income of $754 million also contributed to investor confidence [5]. Competitive Landscape - Rival The Hartford Insurance Group has outperformed Allstate, with shares returning 19.6% year-to-date and 11.9% over the past 52 weeks [6]. - Despite underperformance relative to the Nasdaq, analysts maintain a moderately optimistic outlook on Allstate, with a consensus rating of "Moderate Buy" from 23 analysts and a mean price target of $231.79, representing a 15.8% premium to current levels [6].